Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
System Performance Validation of a Multi-Model Machine Learning-Augmented Multi-Layer SD-OCT Segmentation System for Ellipsoid Zone Integrity and Outer Retinal Features with and without Certified Reader Review
Author Affiliations & Notes
  • Jordan Budrevich
    Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio, United States
  • Reem Amine
    Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio, United States
  • Jon Whitney
    Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio, United States
  • Yavuz Cakir
    Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio, United States
  • Karen Matar
    Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio, United States
  • Hasan Cetin
    Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio, United States
  • Michelle Bonnay
    Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio, United States
  • Jamie Reese
    Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio, United States
  • Sunil K Srivastava
    Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio, United States
  • Justis Ehlers
    Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio, United States
  • Footnotes
    Commercial Relationships   Jordan Budrevich None; Reem Amine None; Jon Whitney None; Yavuz Cakir None; Karen Matar None; Hasan Cetin None; Michelle Bonnay None; Jamie Reese None; Sunil Srivastava Bausch and Lomb, Adverum, Novartis, Regeneron, Code C (Consultant/Contractor), Regeneron, Allergan, Gilead, Code F (Financial Support), Leica, Code P (Patent); Justis Ehlers Zeiss, Leica/Bioptigen, Alcon, Beyeonics. Allergan, Allegro, Adverum, Regeneron, Roche, Genentech, RegenxBIO, Iveric Bio, Boehringer Ingelheim, Apellis, Novartis, Boehringer Ingelheim, Stealth Biotherapeutics, Perceive Biotherapeutics, Exegenesis, Ophthalytics, Eyepoint, Abbvie, Bayer, BVI, Alexion, Code C (Consultant/Contractor), Regeneron, Genentech, Oxurion/Thrombogenics, Alcon, Aerpio, Allergan, Roche, Iveric Bio, Boehringer Ingelheim, Adverum, Novartis, Zeiss, Stealth Biotherapeutics, Perceive Biotherapeutics, Alexion, Beyeonics, Code F (Financial Support), Bioptigen/Leica, Code P (Patent)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2024, Vol.65, OD55. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Jordan Budrevich, Reem Amine, Jon Whitney, Yavuz Cakir, Karen Matar, Hasan Cetin, Michelle Bonnay, Jamie Reese, Sunil K Srivastava, Justis Ehlers; System Performance Validation of a Multi-Model Machine Learning-Augmented Multi-Layer SD-OCT Segmentation System for Ellipsoid Zone Integrity and Outer Retinal Features with and without Certified Reader Review. Invest. Ophthalmol. Vis. Sci. 2024;65(7):OD55.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Enhanced SD-OCT characterization of the outer retina has provided new opportunities for structure/function correlation and new clinical trial endpoints (e.g., ellipsoid zone (EZ) integrity). Accurate, efficient, and reliable segmentation is critical for output reproducibility. The purpose of this study was to validate the reproducibility and agreement of multiple segmentation measures using a multi-model machine learning (ML) enhanced segmentation system with and without certified reader (CR) corrections for outer retinal assessments.

Methods : In this IRB-approved retrospective analysis, SD-OCT scans from four disease groups were analyzed: diabetic macular edema (N=60), dry age-related macular degeneration (AMD, N=60), wet AMD (N=60), and normal (N=33). To evaluate system generalizability, scans were balanced between Zeiss Cirrus (N=108) and Heidelberg Spectrails (N=105). The multi-layer segmentation system consisted of ML models that were trained on a total of 486,155 annotated OCT B-scans across 1303 patients, using a combination of U-Net and Transformer architectures. All scans were initially segmented with the ML system with integrated logic and then evaluated through four methods: semi-automated with sequential dual expert read for use as ground truth, semi-automated with 2 independent CRs, and fully-automated. Intraclass correlation coefficients (ICCs) were calculated for both agreement and consistency.

Results : For evaluation of system performance, 213 patients were included in this analysis across the 4 disease groups. The CR approach and fully automated outputs exhibited outstanding agreement and consistency across numerous parameters and diseases, including highly complex anatomic segmentation, such as EZ integrity. ICCs for outer retinal measures were 0.98-0.99 for ONL-RPE volume, 0.96-0.98 for EZ integrity measures, and 0.94-0.97 for sub-RPE compartment metrics.

Conclusions : This study demonstrates that both CR assessment and fully-automated performance were robust and reliable for outer retinal layer parameters across multiple diseases and OCT systems. Performance was consistent even for historically challenging features to segment, such as EZ integrity, providing validation of this platform and approach for high reliability analysis.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×